Evidence map›Paper›PMID 34077715›Full record

ArticleCell metabolism2021

A newly identified protein from Akkermansia muciniphila stimulates GLP-1 secretion.

Patrice D Cani, Claude Knauf

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cell metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The role ofFrontiers in medicine · 2025
    Pooled it
  2. Trial
  3. The Effects of a Prebiotic Formula PromotingInternational journal of medical sciences · 2026
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Microbe on the move:Journal of bacteriology · 2026
    Review
  13. Review
  14. Review
  15. Frontiers in microbiology · 2026
    Review
  16. Review
  17. Article
  18. The Biology ofAnnual review of microbiology · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Patrice D CaniUCLouvain, Université Catholique de Louvain, WELBIO Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, Brussels, Belgium; International Research Project (IRP), European Lab "NeuroMicrobiota", Brussels/Toulouse, France and Belgium. Electronic address: patrice.cani@uclouvain.be.
Claude KnaufInternational Research Project (IRP), European Lab "NeuroMicrobiota", Brussels/Toulouse, France and Belgium; Université Paul Sabatier, Toulouse III, INSERM U1220, Institut de Recherche en Santé Digestive (IRSD), CHU Purpan, Place du Docteur Baylac, CS 60039, 31024 Toulouse Cedex 3, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Akkermansia muciniphila is a gut commensal known to improve host metabolism. The outer membrane protein Amuc_1100 has been shown to partially replicate these beneficial effects. Here, Yoon et al. (2021) have identified a novel protein (P9) secreted by A. muciniphila that stimulates GLP-1 secretion, thereby adding new insight to the biomolecule era to treat metabolic diseases.

Indexed as

Glucagon-Like Peptide 1Metabolic DiseasesAkkermansiaHumansMembrane ProteinsTranscription FactorsGlucagon-Like Peptide 1Membrane ProteinsTranscription Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.